BYOOVIZ is an FDA-approved biosimilar* to Lucentis® (ranibizumab injection)

*Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences between the biosimilar product and the reference product.

What is BYOOVIZ? Support
and Resources

Lucentis is a registered trademark of Genentech, Inc.